Acepodia, Inc. (TPEX:6976)
Taiwan · Delayed Price · Currency is TWD 11.95
+0.05 (0.42%)
Nov 13, 2026, 1:52 PM CST
Acepodia Market Cap
Acepodia has a market cap or net worth of 6.97 billion as of November 13, 2026. It is the 20,123rd most valuable company in the world and the 867th biggest in Taiwan. Its market cap has decreased by 21.91% in one year.
Market Cap
6.97B
Enterprise Value
3.77B
Revenue
n/a
Global Rank
Country Rank
#867 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since August 8, 2023, Acepodia's market cap has decreased from 22.92B to 6.97B, a decrease of -69.60%. That is a compound annual growth rate of -30.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 6.97B | -22.01% |
| Dec 31, 2025 | 8.94B | -10.43% |
| Dec 31, 2024 | 9.98B | -48.47% |
| Dec 29, 2023 | 19.36B | -15.54% |
| Aug 8, 2023 | 22.92B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OBI Pharma | 8.54B |
| TCM Biotech International | 8.07B |
| PharmaEngine | 7.83B |
| Tanvex BioPharma | 7.45B |
| Locus Cell | 7.35B |
| Adimmune | 7.08B |
| AnnJi Pharmaceutical | 6.56B |
| Polaris Group | 6.39B |